Making sense of differing bowel cancer screening guidelines

Terry D Bolin, Melvyn G Korman and Alistair E Cowen
Med J Aust 2009; 191 (4): . || doi: 10.5694/j.1326-5377.2009.tb02771.x
Published online: 17 August 2009

To the Editor: The recent withdrawal of faulty faecal occult blood testing (FOBT) kits by the government highlights the flaws in the National Bowel Cancer Screening Program (NBCSP), with 475 000 kits needing to be replaced. In their recent editorial,1 Ee and Olynyk attempted to persuade us that the NBCSP, which has now temporarily suspended the issuing of new invitations to participate, is both rational and appropriate for an affluent country such as Australia.

  • Terry D Bolin1
  • Melvyn G Korman2
  • Alistair E Cowen3

  • 1 Gastrointestinal and Liver Clinic, Sydney, NSW.
  • 2 Monash Medical Centre, Melbourne, VIC.
  • 3 Royal Brisbane Hospital, Brisbane, QLD.



remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.